Ergocalciferols

• 

  Subject Areas on Research

  • 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. 
  • Activated injectable vitamin D and hemodialysis survival: a historical cohort study. 
  • Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes. 
  • Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. 
  • Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD. 
  • Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. 
  • Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trial. 
  • Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. 
  • Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis. 
  • Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. 
  • The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia. 
  • Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.